Test Name & Code:
• Test Name: 9p21 (CDKN2A) Deletion
• Test Code: 3065
• Test Code: 3065
Related Diseases & Genes:
• GLIOMA SUSCEPTIBILITY 5; GLM5 (OMIM #: 613030) || Gene: CDKN2A (OMIM #: 600160)
• Bladder cancer, somatic (OMIM #: 109800)
• MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2 (OMIM #: 155601)
• MELANOMA-PANCREATIC CANCER SYNDROME (OMIM #: 606719)
• Bladder cancer, somatic (OMIM #: 109800)
• MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2 (OMIM #: 155601)
• MELANOMA-PANCREATIC CANCER SYNDROME (OMIM #: 606719)
Synonyms:
• del 9p
• 9p deletion
• p16 deletion
• 9p deletion
• p16 deletion
Test Details:
• Methodology: FISH
• Performed: Everyday
• Reported: 1 week
• Performed: Everyday
• Reported: 1 week
Specimen Details:
• Specimen Collection: Peripheral blood; Bone marrow aspiration material; Bone marrow biopsy material
• Container: Tube with Heparin
• Specimen Volume/Amount: > 3 ml
• Storage/Transport Condition: Refrigerated
• Unacceptable Specimens/Conditions: Serum; Frozen specimens; Hemolyzed specimens; Icterus; Lipemia
• Container: Tube with Heparin
• Specimen Volume/Amount: > 3 ml
• Storage/Transport Condition: Refrigerated
• Unacceptable Specimens/Conditions: Serum; Frozen specimens; Hemolyzed specimens; Icterus; Lipemia
Testing Area(s):
• Hemato Oncogenetics
